23 COVID-19 RESPONSE
24
TRACKING VIRUS CHANGES
Tracking how the SARS-CoV-2 virus mutates is a key concern of health officials around the world. All viruses mutate, and as they do, their behavior and the symptoms they produce in their host can change. As it mutates among different populations, scientists have identified three broad SARS-CoV-2 genetic groups present across the globe. Any effective vaccine would need to be able to treat all these strains. Researchers at KAUST are leading efforts to track SARS-CoV-2’s mutation in Saudi Arabia, creating databases that could help health officials prepare for and isolate the most virulent strains of the virus. TRACKING VIRUS MUTATIONS: Scientists and health officials need to collect and analyze thousands of SARS-CoV-2 samples to track mutations. In Saudi Arabia, Professor Arnab Pain and his team at KAUST have been working with the Ministry of Health (MoH) and the Saudi Center for Disease Control and Prevention (CDC) to systematically track mutations in the genetic material of SARS-CoV-2 since the outbreak of the pandemic. Using samples taken from COVID-19-positive individuals in the country, they are building a database of the genomes of SARS-CoV-2 viruses circulating in Saudi Arabia. This data is then analyzed and compared to global datasets to develop an individual genetic ‘barcode’ of all known SARS-CoV-2 viruses. Genetic barcoding
of SARS-CoV-2 viruses can assist public health officials in monitoring virus mutations and transmissions. By combining SARS-CoV-2 genome data with clinical metadata, health officials could potentially identify the genetic features and locations of the most virulent and transmissible local virus strains, and then target interventions accordingly. VIRUS MONITORING: Professor Mo Li’s lab is developing an ultra-sensitive and accurate diagnostics method that can detect and sequence the SARS-CoV-2 virus’ genomes, and provide invaluable data on its mutations. All of this can be done remotely and in real time using a pocket-sized sequencer called Oxford Nanopore minION. Currently, clinicians must ship samples collected in the field to centralized labs, a process which leads to delays and potential sample contamination. Using the Oxford Nanopore minION, clinicians can sample, sequence and detect the virus all in the field. While allowing for quicker diagnosis of infections, this method will also provide invaluable sequencing data that Professor Li’s team will use to monitor the virus’ mutations. Once validated with clinical samples, the diagnosis method being developed by the team will allow clinicians to sequence thousands of virus samples in parallel in a matter of hours, and help health officials track the possible emergence of more virulent strains.
WE WOULD LIKE TO UNDERSTAND HOW THESE COVID-19 CASES – THE VIRUSES THAT ARE CIRCULATING IN THE ARNAB PAIN Professor of Bioscience and Principal Investigator at the Pathogen Genomics Laboratory
KAUST-Impact-190620.indd 24
POPULATION OF SAUDI ARABIA – ARE LINKED TO EACH OTHER, AND MORE IMPORTANTLY, HOW THEY ARE LINKED TO THE REST OF THE WORLD.
26.06.2020 11:36
